Rare and Orphan Diseases - Global Neurology Academy

33-48 of 62

Bridging the Gap: New Consensus Recommendations for Adult DMD Care
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiers
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
- Rosaline Quinlivan
- Ryan Quigley
New Frontiers in the Treatment of DMD Across the Age Spectrum
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CE
New Frontiers in the Treatment of DMD Across the Age Spectrum
1.00 credit
- Crystal Proud, MD
- John Brandsema, MD
- Omer Abdul Hamid, MD
1.00 credit
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
mIDH Gliomas Explained: Characteristics and Management Strategies
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
- Jennie Taylor, MD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Global Neurology Academy
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
- Hans Katzberg, MD
Understanding CIDP: A Roadmap to Diagnosis
Understanding CIDP: A Roadmap to Diagnosis
Global Neurology Academy
Understanding CIDP: A Roadmap to Diagnosis
- Sami Khella, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
- Sami Khella, MD
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD

3/4